Search

everythinglearnresearchcommunity

for

Search:↓

Children's hairlines change shape as they grow, with women often developing a widow's peak and men's hairlines becoming more convex and possibly balding at the temples, influenced by genetics and hormones.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

DA-9401 helps protect rat testis from finasteride damage.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Early surgical treatment for severe facial injuries from high-energy impacts leads to better recovery.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

The document concludes that hair restoration has advanced significantly, with FUE becoming more popular, and stresses the importance of physician training and ethical practices in the field.

A new compound effectively inhibits human 5α-reductase 1.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Wounds can regenerate hair in young mice, but this ability declines with age, offering insights for improving tissue regeneration in the elderly.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Reversing female hair loss.

Human hair varies widely and should be classified by curl type rather than race.

Dr. Shoji Okuda's pioneering work on hair transplantation was overlooked and could have significantly advanced the field if recognized sooner.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Post-finasteride syndrome's existence is uncertain; more research needed.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

The document concludes that multidisciplinary training is important for future cosmetic surgeons and acknowledges the lasting influence of pioneers in the field.

Finasteride doesn't affect bone density in male rats.

Nanoemulgel improves hair growth and quality using finasteride without irritation.